
Whit Bernard, Metsera CEO
Exclusive: Metsera CEO on what it takes to build an obesity biotech in 2025
Metsera, one of the few biotechs to complete an IPO this year, is making its best effort to catch up to the obesity drug giants …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.